| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin ligase complex scaffold activity | 5.26e-05 | 6 | 38 | 2 | GO:0160072 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 4.71e-04 | 17 | 38 | 2 | GO:0070742 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.46e-05 | 96 | 37 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 7.81e-05 | 129 | 37 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | NuRD complex | 4.08e-04 | 17 | 37 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 4.08e-04 | 17 | 37 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.29e-03 | 30 | 37 | 2 | GO:0016514 | |
| MousePheno | abnormal somatosensory cortex morphology | 3.77e-05 | 33 | 28 | 3 | MP:0000859 | |
| MousePheno | abnormal parietal lobe morphology | 5.34e-05 | 37 | 28 | 3 | MP:0000794 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF462 ZNF407 ZNF800 POGZ BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 1.20e-08 | 775 | 36 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF462 ZNF407 ZNF800 POGZ BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 1.23e-08 | 777 | 36 | 12 | PS00028 |
| Domain | Znf_C2H2-like | ZNF462 ZNF407 ZNF800 POGZ BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 1.61e-08 | 796 | 36 | 12 | IPR015880 |
| Domain | Znf_C2H2 | ZNF462 ZNF407 ZNF800 POGZ BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 1.82e-08 | 805 | 36 | 12 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF462 ZNF407 ZNF800 POGZ BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 1.90e-08 | 808 | 36 | 12 | SM00355 |
| Domain | - | ZNF462 ZNF407 ZNF800 BCL11B BCL11A PRDM5 ZNF337 ZXDA ZNF614 ZXDB | 4.07e-07 | 679 | 36 | 10 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF462 ZNF407 POGZ BCL11B BCL11A PRDM5 ZNF337 ZXDA ZNF614 ZXDB | 4.91e-07 | 693 | 36 | 10 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF462 ZNF407 ZNF800 BCL11B BCL11A PRDM5 ZNF337 ZXDA ZNF614 ZXDB | 4.98e-07 | 694 | 36 | 10 | IPR013087 |
| Domain | CHDCT2 | 1.08e-05 | 3 | 36 | 2 | PF08074 | |
| Domain | CHDNT | 1.08e-05 | 3 | 36 | 2 | PF08073 | |
| Domain | DUF1086 | 1.08e-05 | 3 | 36 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.08e-05 | 3 | 36 | 2 | IPR009463 | |
| Domain | DUF1087 | 1.08e-05 | 3 | 36 | 2 | PF06465 | |
| Domain | DUF1086 | 1.08e-05 | 3 | 36 | 2 | PF06461 | |
| Domain | DUF1087 | 1.08e-05 | 3 | 36 | 2 | SM01147 | |
| Domain | DUF1086 | 1.08e-05 | 3 | 36 | 2 | SM01146 | |
| Domain | CHD_N | 1.08e-05 | 3 | 36 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.08e-05 | 3 | 36 | 2 | IPR012957 | |
| Domain | Cullin_CS | 7.54e-05 | 7 | 36 | 2 | IPR016157 | |
| Domain | CULLIN | 7.54e-05 | 7 | 36 | 2 | SM00182 | |
| Domain | Cullin_Nedd8 | 1.00e-04 | 8 | 36 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.00e-04 | 8 | 36 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 1.00e-04 | 8 | 36 | 2 | IPR019559 | |
| Domain | Cullin_homology | 1.29e-04 | 9 | 36 | 2 | IPR016158 | |
| Domain | Cullin_N | 1.61e-04 | 10 | 36 | 2 | IPR001373 | |
| Domain | Cullin | 1.61e-04 | 10 | 36 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.61e-04 | 10 | 36 | 2 | PS50069 | |
| Domain | CULLIN_1 | 1.61e-04 | 10 | 36 | 2 | PS01256 | |
| Domain | Cullin_repeat-like_dom | 2.36e-04 | 12 | 36 | 2 | IPR016159 | |
| Domain | Chromo_domain | 9.71e-04 | 24 | 36 | 2 | IPR023780 | |
| Domain | Chromo | 1.14e-03 | 26 | 36 | 2 | PF00385 | |
| Domain | CHROMO_2 | 1.32e-03 | 28 | 36 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.32e-03 | 28 | 36 | 2 | PS00598 | |
| Domain | SNF2_N | 1.73e-03 | 32 | 36 | 2 | PF00176 | |
| Domain | SNF2_N | 1.73e-03 | 32 | 36 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 1.73e-03 | 32 | 36 | 2 | IPR016197 | |
| Domain | CHROMO | 1.84e-03 | 33 | 36 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.84e-03 | 33 | 36 | 2 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.07e-03 | 35 | 36 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.43e-03 | 38 | 36 | 2 | PS00690 | |
| Domain | Znf_FYVE_PHD | 2.82e-03 | 147 | 36 | 3 | IPR011011 | |
| Pubmed | 1.49e-09 | 103 | 38 | 6 | 32744500 | ||
| Pubmed | BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. | 1.44e-07 | 10 | 38 | 3 | 16091750 | |
| Pubmed | 8.10e-07 | 17 | 38 | 3 | 27806305 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 9.77e-07 | 495 | 38 | 7 | 27705803 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.16e-06 | 2 | 38 | 2 | 7560064 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12196208 | ||
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 1.16e-06 | 2 | 38 | 2 | 11719382 | |
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 1.16e-06 | 2 | 38 | 2 | 15465497 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 8268913 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 1.16e-06 | 2 | 38 | 2 | 35568926 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 7575689 | ||
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 1.16e-06 | 2 | 38 | 2 | 8843877 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 32658897 | ||
| Pubmed | Regulation of pulmonary fibrosis by chemokine receptor CXCR3. | 3.48e-06 | 3 | 38 | 2 | 15254596 | |
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 5.84e-06 | 32 | 38 | 3 | 35813202 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 9326634 | ||
| Pubmed | SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. | 6.96e-06 | 4 | 38 | 2 | 32460168 | |
| Pubmed | SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex. | 6.96e-06 | 4 | 38 | 2 | 21247897 | |
| Pubmed | Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. | 6.96e-06 | 4 | 38 | 2 | 28599312 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 27780719 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 16574654 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 35766181 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 10744719 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 35115401 | ||
| Pubmed | Disruption of Aspm causes microcephaly with abnormal neuronal differentiation. | 6.96e-06 | 4 | 38 | 2 | 24220505 | |
| Pubmed | 9.89e-06 | 38 | 38 | 3 | 33283408 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.07e-05 | 125 | 38 | 4 | 32891193 | |
| Pubmed | Graded expression of Zfp462 in the embryonic mouse cerebral cortex. | 1.16e-05 | 5 | 38 | 2 | 17207666 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 17254749 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 9663463 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 24269809 | ||
| Pubmed | 1.25e-05 | 730 | 38 | 7 | 34857952 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.53e-05 | 289 | 38 | 5 | 23752268 | |
| Pubmed | cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. | 1.74e-05 | 6 | 38 | 2 | 8681378 | |
| Pubmed | The orphan nuclear receptor SHP regulates ER stress response by inhibiting XBP1s degradation. | 1.74e-05 | 6 | 38 | 2 | 31296559 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 23644491 | ||
| Pubmed | Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity. | 1.74e-05 | 6 | 38 | 2 | 17626165 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 35194188 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.82e-05 | 774 | 38 | 7 | 15302935 | |
| Pubmed | Genome-wide association study identifies loci affecting blood copper, selenium and zinc. | 2.14e-05 | 49 | 38 | 3 | 23720494 | |
| Pubmed | 2.28e-05 | 1116 | 38 | 8 | 31753913 | ||
| Pubmed | Strict in vivo specificity of the Bcl11a erythroid enhancer. | 2.43e-05 | 7 | 38 | 2 | 27707736 | |
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 2.43e-05 | 7 | 38 | 2 | 26816381 | |
| Pubmed | Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear localization through Nedd8 modification. | 2.43e-05 | 7 | 38 | 2 | 23776465 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 29695787 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 24082123 | ||
| Pubmed | Basis for metabolite-dependent Cullin-RING ligase deneddylation by the COP9 signalosome. | 2.43e-05 | 7 | 38 | 2 | 32047038 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 11861641 | ||
| Pubmed | De novo DNA methyltransferase DNMT3b interacts with NEDD8-modified proteins. | 2.43e-05 | 7 | 38 | 2 | 20847044 | |
| Pubmed | The COP9 signalosome, cullin 3 and Keap1 supercomplex regulates CHOP stability and adipogenesis. | 2.43e-05 | 7 | 38 | 2 | 23213463 | |
| Pubmed | 2.62e-05 | 157 | 38 | 4 | 30186101 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 3.20e-05 | 56 | 38 | 3 | 26919559 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 12684064 | ||
| Pubmed | Regulation of Cullin-RING ubiquitin ligase 1 by Spliceosome-associated protein 130 (SAP130). | 3.24e-05 | 8 | 38 | 2 | 23951410 | |
| Pubmed | Covalent modification of all members of human cullin family proteins by NEDD8. | 3.24e-05 | 8 | 38 | 2 | 10597293 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 28475037 | ||
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 3.24e-05 | 8 | 38 | 2 | 10655032 | |
| Pubmed | SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1). | 3.24e-05 | 8 | 38 | 2 | 25349211 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 33016927 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.89e-05 | 351 | 38 | 5 | 38297188 | |
| Pubmed | Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity. | 4.16e-05 | 9 | 38 | 2 | 22013077 | |
| Pubmed | Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization. | 4.16e-05 | 9 | 38 | 2 | 24192928 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 25972180 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 17439941 | ||
| Pubmed | Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. | 4.16e-05 | 9 | 38 | 2 | 15448697 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 28935710 | ||
| Pubmed | 4.76e-05 | 183 | 38 | 4 | 36129980 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 4.78e-05 | 608 | 38 | 6 | 36089195 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 26976604 | ||
| Pubmed | Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. | 5.20e-05 | 10 | 38 | 2 | 29160310 | |
| Pubmed | Regulation of cullin RING E3 ubiquitin ligases by CAND1 in vivo. | 5.20e-05 | 10 | 38 | 2 | 21249194 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 37738575 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 28805820 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 27001857 | ||
| Pubmed | TIP120A associates with cullins and modulates ubiquitin ligase activity. | 6.35e-05 | 11 | 38 | 2 | 12609982 | |
| Pubmed | The SCFSkp2 ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L). | 6.35e-05 | 11 | 38 | 2 | 32313199 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 6.35e-05 | 11 | 38 | 2 | 10204490 | |
| Pubmed | 7.28e-05 | 963 | 38 | 7 | 28671696 | ||
| Pubmed | 7.39e-05 | 74 | 38 | 3 | 29795351 | ||
| Pubmed | NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway. | 7.62e-05 | 12 | 38 | 2 | 22466964 | |
| Pubmed | The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. | 7.62e-05 | 12 | 38 | 2 | 19617556 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 22560079 | ||
| Pubmed | SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release. | 7.62e-05 | 12 | 38 | 2 | 17803915 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 11384984 | ||
| Pubmed | SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. | 7.62e-05 | 12 | 38 | 2 | 18826954 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 9885572 | ||
| Pubmed | KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation. | 7.62e-05 | 12 | 38 | 2 | 33173725 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 21326311 | ||
| Pubmed | Mammalian Elongin A complex mediates DNA-damage-induced ubiquitylation and degradation of Rpb1. | 9.00e-05 | 13 | 38 | 2 | 19037258 | |
| Pubmed | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. | 9.00e-05 | 13 | 38 | 2 | 19703393 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 27833851 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 38019816 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 29898395 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 23201271 | ||
| Pubmed | The NEDD8 E3 ligase DCNL5 is phosphorylated by IKK alpha during Toll-like receptor activation. | 9.00e-05 | 13 | 38 | 2 | 29958295 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 10230407 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 33203851 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 17360773 | ||
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 1.05e-04 | 14 | 38 | 2 | 10976766 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 16428440 | ||
| Interaction | ZNF460 interactions | 2.13e-07 | 138 | 38 | 6 | int:ZNF460 | |
| Interaction | FBXO38 interactions | 2.86e-07 | 145 | 38 | 6 | int:FBXO38 | |
| Interaction | CHD5 interactions | 3.25e-07 | 77 | 38 | 5 | int:CHD5 | |
| Interaction | ZNF296 interactions | 3.26e-07 | 31 | 38 | 4 | int:ZNF296 | |
| Interaction | MTA3 interactions | 8.06e-07 | 173 | 38 | 6 | int:MTA3 | |
| Interaction | SHPRH interactions | 1.03e-06 | 97 | 38 | 5 | int:SHPRH | |
| Interaction | MBD3 interactions | 1.15e-06 | 295 | 38 | 7 | int:MBD3 | |
| Interaction | BCL11A interactions | 1.32e-06 | 102 | 38 | 5 | int:BCL11A | |
| Interaction | BCL11B interactions | 1.12e-05 | 74 | 38 | 4 | int:BCL11B | |
| Interaction | CHAF1B interactions | 1.13e-05 | 158 | 38 | 5 | int:CHAF1B | |
| Interaction | PWWP2A interactions | 1.25e-05 | 76 | 38 | 4 | int:PWWP2A | |
| Interaction | PWP2 interactions | 1.71e-05 | 172 | 38 | 5 | int:PWP2 | |
| Interaction | SAP130 interactions | 2.18e-05 | 181 | 38 | 5 | int:SAP130 | |
| Interaction | ZNF219 interactions | 2.44e-05 | 90 | 38 | 4 | int:ZNF219 | |
| Interaction | LIN37 interactions | 2.78e-05 | 93 | 38 | 4 | int:LIN37 | |
| Interaction | ZMYND8 interactions | 2.83e-05 | 191 | 38 | 5 | int:ZMYND8 | |
| Interaction | MYNN interactions | 2.95e-05 | 32 | 38 | 3 | int:MYNN | |
| Interaction | RBBP7 interactions | 3.93e-05 | 507 | 38 | 7 | int:RBBP7 | |
| Interaction | BACC1 interactions | 4.32e-05 | 104 | 38 | 4 | int:BACC1 | |
| Interaction | KLHL12 interactions | 4.32e-05 | 104 | 38 | 4 | int:KLHL12 | |
| Interaction | CPN2 interactions | 5.17e-05 | 6 | 38 | 2 | int:CPN2 | |
| Interaction | FBXO44 interactions | 5.39e-05 | 39 | 38 | 3 | int:FBXO44 | |
| Interaction | LIN9 interactions | 5.57e-05 | 111 | 38 | 4 | int:LIN9 | |
| Interaction | MBD3L2 interactions | 6.27e-05 | 41 | 38 | 3 | int:MBD3L2 | |
| Interaction | CDK2AP1 interactions | 7.07e-05 | 118 | 38 | 4 | int:CDK2AP1 | |
| Interaction | RPS26P54 interactions | 7.23e-05 | 7 | 38 | 2 | int:RPS26P54 | |
| Interaction | ZNF33B interactions | 7.23e-05 | 7 | 38 | 2 | int:ZNF33B | |
| Interaction | RBBP4 interactions | 8.49e-05 | 573 | 38 | 7 | int:RBBP4 | |
| Interaction | CENPB interactions | 8.57e-05 | 124 | 38 | 4 | int:CENPB | |
| Interaction | RPSAP55 interactions | 9.62e-05 | 8 | 38 | 2 | int:RPSAP55 | |
| Interaction | RPS7P4 interactions | 9.62e-05 | 8 | 38 | 2 | int:RPS7P4 | |
| Interaction | RPL21P19 interactions | 9.62e-05 | 8 | 38 | 2 | int:RPL21P19 | |
| Interaction | RPL21P16 interactions | 9.62e-05 | 8 | 38 | 2 | int:RPL21P16 | |
| Interaction | RPL10P16 interactions | 9.62e-05 | 8 | 38 | 2 | int:RPL10P16 | |
| Interaction | KRT84 interactions | 1.07e-04 | 49 | 38 | 3 | int:KRT84 | |
| Interaction | CDK2AP2 interactions | 1.07e-04 | 49 | 38 | 3 | int:CDK2AP2 | |
| Interaction | KRT6B interactions | 1.09e-04 | 132 | 38 | 4 | int:KRT6B | |
| Interaction | RBPJ interactions | 1.09e-04 | 254 | 38 | 5 | int:RBPJ | |
| Interaction | NAB2 interactions | 1.12e-04 | 133 | 38 | 4 | int:NAB2 | |
| Interaction | RPSAP15 interactions | 1.24e-04 | 9 | 38 | 2 | int:RPSAP15 | |
| Interaction | ZNF614 interactions | 1.24e-04 | 9 | 38 | 2 | int:ZNF614 | |
| Interaction | MTREX interactions | 1.26e-04 | 262 | 38 | 5 | int:MTREX | |
| Interaction | FTSJ3 interactions | 1.27e-04 | 422 | 38 | 6 | int:FTSJ3 | |
| Interaction | SUDS3 interactions | 1.41e-04 | 141 | 38 | 4 | int:SUDS3 | |
| Interaction | ZMYM2 interactions | 1.48e-04 | 271 | 38 | 5 | int:ZMYM2 | |
| Interaction | MTA2 interactions | 1.50e-04 | 435 | 38 | 6 | int:MTA2 | |
| Interaction | IGHV3OR15-7 interactions | 1.54e-04 | 10 | 38 | 2 | int:IGHV3OR15-7 | |
| Interaction | HDAC1 interactions | 1.70e-04 | 1108 | 38 | 9 | int:HDAC1 | |
| Interaction | RPL13P12 interactions | 1.88e-04 | 11 | 38 | 2 | int:RPL13P12 | |
| Interaction | RPSAP12 interactions | 1.88e-04 | 11 | 38 | 2 | int:RPSAP12 | |
| Interaction | ADAR interactions | 1.90e-04 | 286 | 38 | 5 | int:ADAR | |
| Interaction | CBX1 interactions | 1.96e-04 | 288 | 38 | 5 | int:CBX1 | |
| Interaction | FBXO5 interactions | 1.97e-04 | 60 | 38 | 3 | int:FBXO5 | |
| Interaction | ZCCHC8 interactions | 1.98e-04 | 154 | 38 | 4 | int:ZCCHC8 | |
| Interaction | KRT9 interactions | 2.03e-04 | 155 | 38 | 4 | int:KRT9 | |
| Interaction | MYBBP1A interactions | 2.11e-04 | 463 | 38 | 6 | int:MYBBP1A | |
| Interaction | RPL36AP37 interactions | 2.26e-04 | 12 | 38 | 2 | int:RPL36AP37 | |
| Interaction | YLPM1 interactions | 2.29e-04 | 160 | 38 | 4 | int:YLPM1 | |
| Interaction | KRT6A interactions | 2.29e-04 | 160 | 38 | 4 | int:KRT6A | |
| Interaction | MBD2 interactions | 2.34e-04 | 161 | 38 | 4 | int:MBD2 | |
| Interaction | BRIX1 interactions | 2.37e-04 | 300 | 38 | 5 | int:BRIX1 | |
| Interaction | MYBL2 interactions | 2.40e-04 | 162 | 38 | 4 | int:MYBL2 | |
| Interaction | ZKSCAN1 interactions | 2.61e-04 | 66 | 38 | 3 | int:ZKSCAN1 | |
| Interaction | ZXDA interactions | 2.67e-04 | 13 | 38 | 2 | int:ZXDA | |
| Interaction | RPL7AP27 interactions | 2.67e-04 | 13 | 38 | 2 | int:RPL7AP27 | |
| Interaction | SAP30 interactions | 2.70e-04 | 167 | 38 | 4 | int:SAP30 | |
| Interaction | RPL10A interactions | 2.86e-04 | 490 | 38 | 6 | int:RPL10A | |
| Interaction | HDAC3 interactions | 2.89e-04 | 313 | 38 | 5 | int:HDAC3 | |
| Interaction | EGR2 interactions | 2.95e-04 | 171 | 38 | 4 | int:EGR2 | |
| Interaction | EHMT2 interactions | 2.97e-04 | 315 | 38 | 5 | int:EHMT2 | |
| Interaction | CPSF2 interactions | 3.08e-04 | 173 | 38 | 4 | int:CPSF2 | |
| Interaction | MBD3L1 interactions | 3.10e-04 | 70 | 38 | 3 | int:MBD3L1 | |
| Interaction | NPM1 interactions | 3.11e-04 | 1201 | 38 | 9 | int:NPM1 | |
| Interaction | EIF4A3 interactions | 3.15e-04 | 499 | 38 | 6 | int:EIF4A3 | |
| Interaction | PRSS1 interactions | 3.51e-04 | 73 | 38 | 3 | int:PRSS1 | |
| Interaction | PHF20L1 interactions | 3.80e-04 | 75 | 38 | 3 | int:PHF20L1 | |
| Interaction | KRT6C interactions | 3.95e-04 | 76 | 38 | 3 | int:KRT6C | |
| Interaction | LUC7L3 interactions | 3.98e-04 | 185 | 38 | 4 | int:LUC7L3 | |
| Interaction | RPS17 interactions | 4.05e-04 | 337 | 38 | 5 | int:RPS17 | |
| Interaction | ZNF644 interactions | 4.06e-04 | 186 | 38 | 4 | int:ZNF644 | |
| Interaction | AMPD1 interactions | 4.09e-04 | 16 | 38 | 2 | int:AMPD1 | |
| Interaction | KRT10 interactions | 4.14e-04 | 187 | 38 | 4 | int:KRT10 | |
| Interaction | EHMT1 interactions | 4.22e-04 | 188 | 38 | 4 | int:EHMT1 | |
| Interaction | SMARCA1 interactions | 4.22e-04 | 188 | 38 | 4 | int:SMARCA1 | |
| Interaction | KRT14 interactions | 4.57e-04 | 192 | 38 | 4 | int:KRT14 | |
| Interaction | ZNF337 interactions | 4.62e-04 | 17 | 38 | 2 | int:ZNF337 | |
| Interaction | FBXL20 interactions | 4.62e-04 | 17 | 38 | 2 | int:FBXL20 | |
| Interaction | KRT5 interactions | 4.67e-04 | 193 | 38 | 4 | int:KRT5 | |
| Interaction | U2SURP interactions | 4.75e-04 | 349 | 38 | 5 | int:U2SURP | |
| Interaction | POLR1E interactions | 4.81e-04 | 350 | 38 | 5 | int:POLR1E | |
| Interaction | KPNA1 interactions | 4.88e-04 | 351 | 38 | 5 | int:KPNA1 | |
| Interaction | ZNF512B interactions | 4.94e-04 | 196 | 38 | 4 | int:ZNF512B | |
| Interaction | RPL4 interactions | 4.95e-04 | 764 | 38 | 7 | int:RPL4 | |
| Interaction | BPTF interactions | 5.04e-04 | 197 | 38 | 4 | int:BPTF | |
| Interaction | KRT16 interactions | 5.04e-04 | 197 | 38 | 4 | int:KRT16 | |
| Interaction | CBX5 interactions | 5.20e-04 | 356 | 38 | 5 | int:CBX5 | |
| Interaction | ADNP interactions | 5.24e-04 | 199 | 38 | 4 | int:ADNP | |
| Interaction | COIL interactions | 5.38e-04 | 552 | 38 | 6 | int:COIL | |
| Interaction | TXN interactions | 5.47e-04 | 360 | 38 | 5 | int:TXN | |
| Interaction | FEV interactions | 5.64e-04 | 203 | 38 | 4 | int:FEV | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF462 ZNF407 ZNF800 BCL11B BCL11A PRDM5 ZNF337 ZHX1 ZXDA ZNF614 ZXDB | 6.46e-09 | 718 | 29 | 11 | 28 |
| GeneFamily | Cullins | 6.91e-05 | 8 | 29 | 2 | 1032 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.62e-04 | 12 | 29 | 2 | 1305 | |
| GeneFamily | PHD finger proteins | 9.12e-03 | 90 | 29 | 2 | 88 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN | 8.05e-06 | 191 | 38 | 5 | M9977 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-2fold-vs-M_top255_255 | 1.65e-07 | 233 | 38 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-2fold-vs-M | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 7.61e-07 | 40 | 38 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.01e-06 | 271 | 38 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.33e-05 | 492 | 38 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.38e-05 | 978 | 38 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | ASPM MRPL10 ANKRD11 ZNF462 C11orf87 ZNF800 PAPOLA DROSHA APC2 | 4.97e-05 | 994 | 38 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 1.07e-04 | 850 | 38 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.75e-04 | 157 | 38 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.04e-04 | 306 | 38 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.90e-04 | 72 | 38 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 2.90e-04 | 983 | 38 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_200 | 3.68e-04 | 16 | 38 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.06e-04 | 196 | 38 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#1_top-relative-expression-ranked_200 | 4.69e-04 | 18 | 38 | 2 | gudmap_developingGonad_P2_ovary_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 4.81e-04 | 801 | 38 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 5.23e-04 | 19 | 38 | 2 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.00e-07 | 198 | 38 | 5 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.00e-07 | 198 | 38 | 5 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-05 | 167 | 38 | 4 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 168 | 38 | 4 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-05 | 195 | 38 | 4 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 198 | 38 | 4 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 198 | 38 | 4 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-05 | 198 | 38 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | e4f0bb57be1112869c7068d0a789c2b802a442dd | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | 7.13e-06 | 834 | 38 | 9 | ctd:C513635 | |
| Disease | Intellectual Disability | 9.98e-07 | 447 | 36 | 7 | C3714756 | |
| Disease | Apraxia of Phonation | 4.34e-06 | 3 | 36 | 2 | C0264611 | |
| Disease | Neurodevelopmental Disorders | 5.04e-06 | 93 | 36 | 4 | C1535926 | |
| Disease | Malignant neoplasm of salivary gland | 2.28e-05 | 45 | 36 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 2.61e-05 | 47 | 36 | 3 | C0036095 | |
| Disease | Adenoid Cystic Carcinoma | 2.49e-04 | 100 | 36 | 3 | C0010606 | |
| Disease | fetal hemoglobin measurement | 3.00e-04 | 21 | 36 | 2 | EFO_0004576 | |
| Disease | Global developmental delay | 5.73e-04 | 133 | 36 | 3 | C0557874 | |
| Disease | executive function measurement | 1.11e-03 | 376 | 36 | 4 | EFO_0009332 | |
| Disease | diet measurement | 1.55e-03 | 1049 | 36 | 6 | EFO_0008111 | |
| Disease | neuropsychological test | 1.78e-03 | 197 | 36 | 3 | EFO_0003926 | |
| Disease | susceptibility to common cold measurement | 1.99e-03 | 54 | 36 | 2 | EFO_0008417 | |
| Disease | risk-taking behaviour | 2.23e-03 | 764 | 36 | 5 | EFO_0008579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKLLRRHSMQIEQMK | 511 | P0C6C1 | |
| ERHKRHKERMKQMEK | 1596 | Q6UB99 | |
| HKERMKQMEKLRHRS | 1601 | Q6UB99 | |
| KHVVHMRVKKLLVSR | 71 | Q9UKJ8 | |
| HHMKRMMAKREKIIK | 86 | Q9NXL2 | |
| KLHDMIIKRRKMLRQ | 181 | P40617 | |
| MARHKRGHQKIILML | 276 | Q5JU67 | |
| RGKKARRHLKMMHIA | 2251 | Q8IZT6 | |
| AFSLKKMLIRHKMTH | 581 | Q9NQX1 | |
| QASKLKRHMKTHMHK | 416 | Q9H165 | |
| RNRMMSTHKSKKKIR | 36 | Q9NX36 | |
| RTRQMKMKVHRFKQT | 1291 | Q86UR5 | |
| MKIAAMHVKRKQLHQ | 481 | P51003 | |
| MLRNLVHSKHKMIAM | 671 | O95996 | |
| QASKLKRHMKTHMHK | 466 | Q9C0K0 | |
| QVAKRKMMLTHLVVR | 1196 | Q12873 | |
| VRIMKMRKVLKHQQL | 716 | Q13616 | |
| AIVRIMKSRKKMQHN | 706 | Q13618 | |
| MVEKKILMKVHSRFI | 236 | Q15835 | |
| QVAKKKMMLTHLVVR | 1186 | Q14839 | |
| KRTAKHIMEKMHLHM | 71 | Q8IVF4 | |
| KILFIRMLHNKHVMV | 236 | O43903 | |
| KVHHMHMRKKGINTL | 931 | Q9NRR4 | |
| KRLKNNIRFMNHMKH | 501 | Q7Z3K3 | |
| KHMQEMKKKRNRRHH | 751 | O95025 | |
| TFHIHKRRMKKRKMQ | 81 | Q6NUJ2 | |
| KHSMKTHMVKRHKVG | 561 | P98169 | |
| LMRHQLRKHKILMKV | 111 | Q7Z7H8 | |
| MMKKRTSHKKHRSSV | 26 | Q9Y657 | |
| RMKALRMLVKVMHVH | 311 | A2RTY3 | |
| MMKNKVENKRIAVHH | 186 | Q9UKY1 | |
| KLKHMVLDKMHARAR | 1011 | Q9NW08 | |
| SKHSMKTHMVKRHKV | 556 | P98168 | |
| HMMKKHRSMVKILSS | 261 | Q96JM2 | |
| QIMLKRHMQIVHKIT | 371 | Q2TB10 | |
| MTRHAATEKHKMKRQ | 1061 | Q9C0G0 | |
| MAHIRKVMKTIEHMK | 2226 | Q9BXT5 | |
| LSNLVKHKKMHTREM | 551 | Q8N883 | |
| KHKKMHTREMGRISQ | 556 | Q8N883 | |
| RKMMVIIHKKAHSRQ | 191 | Q9Y3M9 |